Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation
Indexado
WoS WOS:000714609400003
Scopus SCOPUS_ID:85114508840
DOI 10.1016/J.JNS.2021.118072
Año 2021
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Objective: Currently, there are several reasons to promote worldwide the concept of multiple sclerosis care units (MSCU) for a better management of affected patients. Ideally, the MSCU should have some human and technical resources that distinguish and improve the care of affected patients; however, local, and regional aspects should be considered when recommending how these units should operate. The objective of these consensus recommendations was to review how MSCU should work in Latin America to improve long-term outcomes in MS patients. Methods: A panel of neurology experts from Latin America dedicated to the diagnosis and care of MS patients gathered virtually during 2019 and 2020 to carry out a consensus recommendation about objectives and functioning implementation of MSCU in Latin America. To achieve consensus, the methodology of “formal consensus-RAND/UCLA method” was used. Results: Recommendations focused on the objectives, human and technical resources, and the general functioning that MSCU should have in Latin America. Conclusions: The recommendations of these consensus guidelines attempt to optimize the health care and management of MS patients by setting how MSCU should work in our region.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Neurosciences
Clinical Neurology
Scopus
Neurology (Clinical)
Neurology
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Cristiano, Edgardo Hombre Centro de Esclerosis Múltiple de Buenos Aires - Argentina
Ctr Esclerosis Multiple Buenos Aires - Argentina
2 Abad, Patricio Hombre Hospital Metropolitano - Ecuador
Hosp Metropolitan Quito - Ecuador
Neurol PUCE - Ecuador
3 Becker, Jefferson Hombre Pontifica Universidade Católica do Rio Grande do Sul - Brasil
Pontifical Catholic Univ Rio Grande do Sul PUCRS - Brasil
4 Carra, Adriana Mujer Hospital Británico de Buenos Aires - Argentina
Fundacion Favaloro - Argentina
MS Sect Hosp Britan Buenos Aires - Argentina
Neurociencias Fdn Favaloro INECO - Argentina
5 Correale, Jorge Hombre Fundacion Para La Lucha Contra Las Enfermedades Neurologicas de La Infancia - Argentina
Dept Neurol - Argentina
6 Flores, Jose Hombre Instituto Nacional de Neurología y Neurocirugía - México
Centro Neurológico ABC Santa Fé - México
Inst Nacl Neurol & Neurocirug - México
Ctr Neurol ABC Santa Fe - México
Centro Médico ABC Santa Fe - México
7 Fruns, Manuel Hombre Clínica Las Condes - Chile
8 Garcea, Orlando Hombre Hospital J.M. Ramos Mejia, Buenos Aires - Argentina
Hosp Ramos Mejia - Argentina
9 Garcia-Bonitto, Juan Hombre Sistema Nacional De Salud Colombiano - Colombia
Sistema Nacl Salud Colombian - Colombia
10 Gracia, Fernando Hombre Universidad Interamericana de Panamá - Panamá
Univ Interamer Panama - Panamá
11 Hamuy, Fernando Hombre Hospital IMT - Paraguay
Departamento de Neurologia de Diagnóstico Codas Thompson - Paraguay
Hosp IMT - Paraguay
Dept Neurol Diagnost Codas Thompson - Paraguay
12 Navas, Cárlos Hombre Clinica Enfermedad Desmielinizante Clinica Universitaria Colombia - Colombia
Clin Univ Colombia - Colombia
13 Patrucco, Liliana Mujer Instituto Universitario del Hospital Italiano de Buenos Aires - Argentina
Hospital Británico de Buenos Aires - Argentina
Hosp Italian Buenos Aires - Argentina
14 Rivera, Victor M. Hombre Baylor College of Medicine - Estados Unidos
BAYLOR COLL MED - Estados Unidos
15 Velazquez, Merced - Unidad de Investigación en Salud de Chihuahua - México
Unidad Invest Salud Chihuahua - México
16 Rojas, Juan Ignacio Hombre Centro de Esclerosis Múltiple de Buenos Aires - Argentina
Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno - Argentina
16 Rojas, Juan I. Hombre Ctr Esclerosis Multiple Buenos Aires - Argentina
Hosp Univ CEMIC - Argentina
Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno - Argentina

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Novartis
Universitat Autònoma de Barcelona
Sanofi
Bayer
AstraZeneca
Merck
UCB Pharma
Shire
Roche
Genzyme
Biogen
Ipsen
Merck-Serono
American Academy of Neurology
Teva Pharmaceutical Industries
Universidad Aut?noma de Barcelona
LACTRIMS
CMSC
Horizon CME

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Research was supported by a grant from LACTRIMS.EC has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis, and Roche. JIR has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. TA has received consulting fees, lecture honoraria and Travel Support from Biogen, Merck, Roche and Teva. JB has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Bayer, Biogen, Ipsen, Merck, Novartis, Roche, Sanofi, Teva. JF has received consulting fees from Biogen, Novartis, and Genzyme, as a lecturer from Merck Serono, Novartis and Biogen, and collaboration for attendance to national and international congresses from Biogen, Novartis, Merck Serono, Bayer and Gador. FG has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis, Bayer. OG has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. CN has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Stendhal, Roche, Biogen, Genzyme, Merck, Novartis, Biopas. JGB has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Stendhal, Roche, Biogen, Genzyme, Merck, Novartis. LP has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. JC has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. PA has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Bayer, Biogen, Ipsen, Merck, Novartis, Roche, Sanofi, Teva. AC has received honoraria as speaker honoraria from Biogen, Novartis, Genzyme, TEVA, Merck, Roche, Bayer and participated in advisory boards from Shire, Roche, TEVA, Merck-Serono. VR has received honoraria as speaker from the American Academy of Neurology, ACTRIMS, EMD Serono, Biogen, Stendhal Pharmaceuticals, MS American Association, Horizon CME. Travel: CMSC, LACTRIMS, MEXCTRIMS. Honorarium from Universidad Autónoma de Barcelona. MV has received honoraria speaker from Astra Zeneca, Bayer, Biogen, Bristol Myers, Chiesi, Chiltern, Genzyme, Glaxo, GTR, GW Pharma, Jansen Cilag, Medivector, Merck, Novartis, Pfizer, Roche, Sanofi, Servier, Thrombosis Research Institute and UCB Pharma.
Research was supported by a grant from LACTRIMS .
Research was supported by a grant from LACTRIMS.

Muestra la fuente de financiamiento declarada en la publicación.